Lakeshore Biopharma Executes 10-for-1 Reverse Stock Split
I'm PortAI, I can summarize articles.
Lakeshore Biopharma Co., Ltd executed a 10-for-1 reverse stock split on October 1, 2024, consolidating every 10 shares into one. This action was taken to comply with Nasdaq listing requirements. The announcement was published via PR Newswire on September 12, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments